Author

Martin Bernert

Institution: University of the Witwatersrand

Observed institution: University of the Witwatersrand

OpenAlex ID: A5081271680

Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity

2015 · Kerrilyn Naidoo, Sibusiso T. Malindisa, et al. · PLoS ONE · 29

Patented therapeutic approaches targeting LRP/LR for cancer treatment

2019 · Leila Vania, Gavin Morris, et al. · Expert Opinion on Therapeutic Patents · 26

37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markersin vitro

2017 · Tyrone C. Otgaar, Eloise Ferreira, et al. · Oncotarget · 18

Downregulation of LRP / LR with siRNA inhibits several cancer hallmarks in lung cancer cells

2022 · Monique J. Bignoux, Tyrone C. Otgaar, et al. · FEBS Open Bio · 5

PLGA nanocapsules as a delivery system for a recombinant LRP ‐based therapeutic

2024 · Martin Bernert, Monique J. Bignoux, et al. · FEBS Open Bio · 3

Investigating telomere dynamics in oesophageal squamous carcinoma cells using standard and gold nanoparticle-based assays

2017 · Martin Bernert · 1

37 kDa LRP::FLAG enhances telomerase activity and reduces ageing markers in vivo

2025 · Tyrone C. Otgaar, Martin Bernert, et al. · Cellular and Molecular Life Sciences

Author response for " PLGA nanocapsules as a delivery system for a recombinant LRP ‐based therapeutic"

2024 · Martin Bernert, Monique J. Bignoux, et al.

Works count: 9

Citation count: 82

H-index: 4

I10-index: 3